Schedule 13D ownership disclosure

TELESIS BIO INC

Security class unavailable · CUSIP: 192003101

Event date: 2024-06-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-158510
Form type
SC 13D/A
Filer
Novalis LifeSciences Investments II, L.P.
CIK
CIK 1890017
Filed
Jun 10, 2024
Reporting period
Jun 06, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub